The Premium Business Information Source™

  

 

Pronova BioPharma AS Vollsveien 6 Lysaker, 1366 Norway Tel: 47-22-534850 URL: http://www.pronova.com/ Formerly known as: Pronova Biocare Primary Symbol & Exchange: PRON - Common stock - Oslo Industry: Biotechnology +  SIC Industry Code: 2834 - Pharmaceutical Preparations +  NAICS Industry Codes: 325412 - Pharmaceutical Preparation Manufacturing 541710 - Research and Development in the Physical, Engineering, and Life Sciences Thomson Financial Business Description: The Group's principal activity is to develop and manufacture marine-originated omega3 derived pharmaceutical products. The Group's main brand is Omacor (Lovaza in the USA), prescribed for the treatment of elevated levels of triglycerides in humans, and also approved in certain markets for the secondary prevention of post-myocardial infarction. The Group operates in the United States, Europe and the rest of the World. Alacra Alerts:    Receive alerts on the latest reports on Pronova BioPharma AS Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:

Sorry, no results found in this category    Sorry, no results found in this category

Search for more premium content on Pronova BioPharma AS

Copyright © 2009 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.